This new, thoroughly revised second edition of the Clinical Manual of Child and Adolescent Psychopharmacology is designed to help clinicians provide state-of-the-art care to their patients and keep up to date with the most recent research. It reflects the reality that child and adolescent psychiatry in general, and psychopharmacology in particular, are rapidly progressing fields that are advancing in multiple directions at once. Because pharmacokinetic processes in children and adolescents can vary significantly from those in adults, it is critical that clinicians have access to the latest information on indications, medications, dosages, interactions, side effects, and off-label use for the pediatric patient population.
The book offers clinicians comprehensive information and a multitude of helpful features. Specifically, it:
Thoroughly describes and explores those elements that are specific to pediatric psychopharmacology and make it a distinct discipline at the crossroads of child and adolescent psychiatry, pediatrics, and pharmacology. Boasts a Contributors list of leading clinician/scientists, whose insight into the latest research findings and analysis of their clinical implications enable readers to incorporate those findings into their clinical practice. Takes an evidence-based approach to controversial issues in pediatric psychopharmacology, such as attention-deficit/hyperactivity disorder (ADHD) diagnosis and its treatment with psychostimulants, as well as pediatric mood disorders, including bipolar disorder. Examines advances that have been made in understanding the long-term treatment effects of medications in pediatric populations, including the results of head-to-head medication comparison studies that have been completed since the first edition was published. Analyzes recent studies of combination therapies, so that clinicians will better understand how to treat the complex patients that they see every day.
Clinicians who bought the first edition will want this revision, as will those just venturing into the pharmacological treatment of children and adolescents. Utterly current, comprehensive, and compelling, the Clinical Manual of Child and Adolescent Psychopharmacology, Second Edition, reflects the major steps that have been made toward improving the evidence-based practice of treating young people with psychiatric illness.
|Publisher:||American Psychiatric Publishing, Incorporated|
|Sold by:||Barnes & Noble|
|File size:||5 MB|
|Age Range:||18 Years|
About the Author
Molly McVoy, M.D., is Assistant Training Director of the Child and Adolescent Psychiatry Fellowship within the Division of Child and Adolescent Psychiatry at University Hospitals Case Medical Center, a research physician at the Discovery and Wellness Center for Children, and Assistant Professor of Psychiatry at Case Western Reserve University School of Medicine in Cleveland, Ohio.
Robert L. Findling, M.D., M.B.A., is Director of the Division of Child and Adolescent Psychiatry at University Hospitals Case Medical Center, and Professor of Psychiatry and Pediatrics at Case Western Reserve University School of Medicine in Cleveland, Ohio.
Table of Contents
ContributorsDisclosure of Competing InterestsForewordPrefaceAcknowledgmentsChapter 1. Developmental Aspects of Pediatric PsychopharmacologyChapter 2. Attention-Deficit/Hyperactivity Disorder Chapter 3. Disruptive Behavior Disorders and AggressionChapter 4. Anxiety DisordersChapter 5. Major Depressive DisorderChapter 6. Bipolar DisordersChapter 7. Autism and Other Pervasive Developmental DisordersChapter 8. Tic DisordersChapter 9. Early Schizophrenia and Psychotic Illnesses Index
What People are Saying About This
This new edition is exactly what clinicians need to keep up-to-date on the rapid progress in research on the use of medications to address emotional and behavioral symptoms in children and adolescents. McVoy, Findling, and many expert authors have fully updated the content to enhance evidence-based practice, including both positive and possible negative effects of medications. This book should be on the shelf of every fellow and practitioner in child and adolescent psychiatry, pediatrician, family physician, psychiatric advanced practice nurse, and general psychiatrist who treats children and adolescents. Social workers, psychologists, special education professionals, and those who direct programs in child welfare or juvenile justice will also find important information here.